Skip to content

NAGE NAGE Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
Lifevantage Corporation logo
Lifevantage CorporationLFVN
NuSkin Enterprises logo
NuSkin EnterprisesNUS
USANA Health Sciences logo
USANA Health SciencesUSNA
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's common stock, shares issued (in shares)?
NAGE (NAGE) reported common stock, shares issued (in shares) of $79.46M in Q1 2026.
How has NAGE's common stock, shares issued (in shares) changed year-over-year?
NAGE's common stock, shares issued (in shares) increased by 1.3% year-over-year, from $78.43M to $79.46M.
What is the long-term trend for NAGE's common stock, shares issued (in shares)?
Over 3 years (2022 to 2025), NAGE's common stock, shares issued (in shares) has grown at a 2.2% compound annual growth rate (CAGR), from $74.57M to $79.71M.